<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font20 { font-size : 20; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font27 { font-size : 27; } .font11 { font-size : 11; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; } .font15 { font-size : 15; }</style>
 <body>
  <p>
   <span class="font30">the </span>
   <span class="font27">and </span>
   <span class="font21">with </span>
   <span class="font20">treatment </span>
   <span class="font17">for </span>
   <span class="font16">HCV </span>
   <span class="font15">patients </span>
   <span class="font15">were </span>
   <span class="font14">hepatitis </span>
   <span class="font14">was </span>
   <span class="font14">PWID </span>
   <span class="font14">who </span>
   <span class="font14">SVR </span>
   <span class="font14">{background </span>
   <span class="font13">LTFU </span>
   <span class="font13">that </span>
   <span class="font13">after </span>
   <span class="font12">The </span>
   <span class="font12">infection </span>
   <span class="font12">margin </span>
   <span class="font12">people </span>
   <span class="font12">{border-style </span>
   <span class="font12">drug </span>
   <span class="font12">analysis </span>
   <span class="font12">are </span>
   <span class="font12">chronic </span>
   <span class="font12">liver </span>
   <span class="font12">px;} </span>
   <span class="font12">therapy </span>
   <span class="font12">use </span>
   <span class="font12">#ffffff;} </span>
   <span class="font12">our </span>
   <span class="font12">(.%) </span>
   <span class="font12">antiviral </span>
   <span class="font12">virus </span>
   <span class="font12">not </span>
   <span class="font11">DAA </span>
   <span class="font11">between </span>
   <span class="font11">had </span>
   <span class="font11">follow </span>
   <span class="font11">inject </span>
   <span class="font11">real-world </span>
   <span class="font11">DAAs </span>
   <span class="font11">from </span>
   <span class="font11">genotype </span>
   <span class="font11">rates </span>
   <span class="font11">testing </span>
   <span class="font11">clinical </span>
   <span class="font11">data </span>
   <span class="font11">drugs </span>
   <span class="font11">population </span>
   <span class="font11">response </span>
   <span class="font11">disease </span>
   <span class="font11">rate </span>
   <span class="font11">reported </span>
   <span class="font11">test </span>
   <span class="font11">weeks </span>
   <span class="font11">LTFU. </span>
   <span class="font11">RNA </span>
   <span class="font11">active </span>
   <span class="font11">among </span>
   <span class="font11">completion </span>
   <span class="font11">during </span>
   <span class="font11">parallel </span>
   <span class="font11">px; </span>
   <span class="font11">those </span>
   <span class="font11">while </span>
   <span class="font11">{font-family </span>
   <span class="font10">However, </span>
   <span class="font10">[]. </span>
   <span class="font10">age </span>
   <span class="font10">associated </span>
   <span class="font10">characteristics </span>
   <span class="font10">did </span>
   <span class="font10">direct-acting </span>
   <span class="font10">factors </span>
   <span class="font10">font-size </span>
   <span class="font10">have </span>
   <span class="font10">opioid </span>
   <span class="font10">prospective </span>
   <span class="font10">regression </span>
   <span class="font10">sustained </span>
   <span class="font10">this </span>
   <span class="font10">virological </span>
   <span class="font10">years </span>
   <span class="font10">&amp;lt; </span>
   <span class="font10">Hepatol </span>
   <span class="font10">Our </span>
   <span class="font10">Table </span>
   <span class="font10">all </span>
   <span class="font10">antivirals </span>
   <span class="font10">any </span>
   <span class="font10">double; </span>
   <span class="font10">follow-up </span>
   <span class="font10">history </span>
   <span class="font10">lower </span>
   <span class="font10">might </span>
   <span class="font10">receiving </span>
   <span class="font10">results </span>
   <span class="font10">study </span>
   <span class="font10">substitution </span>
   <span class="font10">treated </span>
   <span class="font10">%CI </span>
   <span class="font10">(OR </span>
   <span class="font10">.-.; </span>
   <span class="font10">Gastroenterol </span>
   <span class="font10">September </span>
   <span class="font10">acting </span>
   <span class="font10">available </span>
   <span class="font10">baseline </span>
   <span class="font10">border-color </span>
   <span class="font10">border-width </span>
   <span class="font10">care </span>
   <span class="font10">cohort </span>
   <span class="font10">complete </span>
   <span class="font10">could </span>
   <span class="font10">direct </span>
   <span class="font10">included </span>
   <span class="font10">lost </span>
   <span class="font10">may </span>
   <span class="font10">observed </span>
   <span class="font10">other </span>
   <span class="font10">patient </span>
   <span class="font10">significant </span>
   <span class="font10">similar </span>
   <span class="font10">solid; </span>
   <span class="font10">treatment. </span>
   <span class="font10">{font-style </span>
   <span class="font10">{font-weight </span>
   <span class="font10">(DAAs) </span>
   <span class="font10">(PWID) </span>
   <span class="font10">Athens, </span>
   <span class="font10">Drug </span>
   <span class="font10">General </span>
   <span class="font10">Greece </span>
   <span class="font10">Hepat </span>
   <span class="font10">ITT </span>
   <span class="font10">LTFU, </span>
   <span class="font10">P=.) </span>
   <span class="font10">PWID, </span>
   <span class="font10">Patients </span>
   <span class="font10">Policy </span>
   <span class="font10">Study </span>
   <span class="font10">This </span>
   <span class="font10">Viral </span>
   <span class="font10">addiction </span>
   <span class="font10">adherence </span>
   <span class="font10">adverse </span>
   <span class="font10">also </span>
   <span class="font10">association </span>
   <span class="font10">been </span>
   <span class="font10">bold </span>
   <span class="font10">cirrhosis </span>
   <span class="font10">considered </span>
   <span class="font10">courier; </span>
   <span class="font10">efficacy </span>
   <span class="font10">em; </span>
   <span class="font10">experience </span>
   <span class="font10">fibrosis </span>
   <span class="font10">general </span>
   <span class="font10">health </span>
   <span class="font10">high </span>
   <span class="font10">higher </span>
   <span class="font10">illicit </span>
   <span class="font10">initiation </span>
   <span class="font10">injecting </span>
   <span class="font10">logistic </span>
   <span class="font10">main </span>
   <span class="font10">majority </span>
   <span class="font10">many </span>
   <span class="font10">more </span>
   <span class="font10">one </span>
   <span class="font10">performed </span>
   <span class="font10">period </span>
   <span class="font10">pt;} </span>
   <span class="font10">rates. </span>
   <span class="font10">real </span>
   <span class="font10">recent </span>
   <span class="font10">regarding </span>
   <span class="font10">setting </span>
   <span class="font10">should </span>
   <span class="font10">showed </span>
   <span class="font10">shown </span>
   <span class="font10">stages </span>
   <span class="font10">studies </span>
   <span class="font10">therapy. </span>
   <span class="font10">towards </span>
   <span class="font10">treat </span>
   <span class="font10">using </span>
  </p>
 </body>
</html>
